ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Maat Pharma SA

Maat Pharma SA (MAAT)

7.40
0.00
(0.00%)
Closed July 23 11:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
7.40
Bid
7.34
Ask
7.40
Volume
706
7.30 Day's Range 7.40
4.50 52 Week Range 9.90
Market Cap
Previous Close
7.40
Open
7.40
Last Trade
15
@
7.4
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,102
Shares Outstanding
11,616,199
Dividend Yield
-
PE Ratio
-4.36
Earnings Per Share (EPS)
-1.7
Revenue
2.23M
Net Profit
-19.72M

About Maat Pharma SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Lyon, Rhone, Fra
Founded
1970
Maat Pharma SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker MAAT. The last closing price for Maat Pharma was 7.40 €. Over the last year, Maat Pharma shares have traded in a share price range of 4.50 € to 9.90 €.

Maat Pharma currently has 11,616,199 shares outstanding. The market capitalization of Maat Pharma is 85.96 € million. Maat Pharma has a price to earnings ratio (PE ratio) of -4.36.

MAAT Latest News

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

Article 223-16 of the General Regulations of the Financial Markets Authority (AMF - Autorité des Marchés Financiers) Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a...

MaaT Pharma: Half-year Report and an Increase of the Resources Allocated to the Liquidity Contract With Kepler Cheuvreux

Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...

MaaT Pharma annonce le résultat positif du premier DSMB pour l'essai clinique de Phase 2 en cours évaluant MaaT033 pour les patients recevant une allo-GCSH

Le DSMB (Data Safety and Monitoring Board), un comité d’experts indépendants, a recommandé que l'essai se poursuive comme prévu et sans modifications. MaaT033 a montré un profil de sécurité...

MaaT Pharma Announces Initiation of Coverage of its Stock by Stifel with a Buy Rating and a Target Price of EUR 16

Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...

MaaT Pharma Appoints Gianfranco Pittari, M.D. Ph.D, as Chief Medical Officer

Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...

MaaT Pharma: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social

Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers Regulatory News: MaaT Pharma (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé...

MaaT Pharma Presents the Results of its Annual Ordinary and Extraordinary General Meeting

Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...

MaaT Pharma announces the successful completion of its Global Offering of 19.2 Million Euros

Regulatory News: THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.06-0.8042895442367.467.57.34647.4025323DE
40.162.209944751387.248.14716807.70621499DE
12-2.1-22.10526315799.59.586.5221027.8377777DE
260.162.209944751387.249.96.5217908.16968804DE
521.0215.9874608156.389.94.517317.33545966DE
156-6.1-45.185185185213.514.44.513419.50666239DE
260-6.1-45.185185185213.514.44.513419.50666239DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALLRAllarity Therapeutics Inc
$ 0.32
(92.19%)
36.93M
NIVFNewGenIvf Group Ltd
$ 1.44
(65.35%)
3.81M
NUZENuZee Inc
$ 1.50
(45.63%)
237.83k
SLNASelina Hospitality PLC
$ 0.03165
(21.73%)
38.9M
DRMADermata Therapeutics Inc
$ 1.53
(17.69%)
94.33k
VSTMVerastem Inc
$ 2.74
(-23.68%)
376.59k
SLRXSalarius Pharmaceuticals Inc
$ 2.17
(-16.86%)
207.47k
MINMMinim Inc
$ 2.43
(-14.74%)
18.39k
ALPPAlpine 4 Holdings Inc
$ 0.512
(-14.65%)
292.67k
CJETChijet Motor Company Inc
$ 4.35
(-14.37%)
88.64k
SLNASelina Hospitality PLC
$ 0.03165
(21.73%)
38.9M
ALLRAllarity Therapeutics Inc
$ 0.32
(92.19%)
36.93M
TSLATesla Inc
$ 234.80
(-4.70%)
12.35M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.4297
(-9.27%)
10.49M
HOLOMicroCloud Hologram Inc
$ 0.595
(1.74%)
8.57M

Discussion

View Full Feed
MrAce MrAce 3 minutes ago
.20 by Friday??
KBLB
Going_4_It Going_4_It 4 minutes ago
NuScale bid on building Ghana's first nuclear reactor.

"Why-Everyone-Wants-a-Piece-of-Ghanas-Nuclear-Energy-Sector."

Article from July 16:

https://oilprice.com/Alternative-Energy/Nuclear-Power/Why-Everyone-Wants-a-Piece-of-Ghanas-Nuclear-Energy-Sector.htm
SMR
bgoat bgoat 4 minutes ago
Hey Jazz, I hope they do! That will bring more attention to how massive this is!!! tick tick tick ...BOOM!!
SPZI
chuck4345 chuck4345 4 minutes ago
Not in our lifetime
SHIBUSD
blackhawks blackhawks 4 minutes ago
Vance is worse. The contemptuous remarks he made about Trump in '16 were prescient. He is an unprincipled, ends justify the means, windsock and a moral imbecile. Similar to Trump, but worse for someone with a law degree.

J.D do your Emily Litella: The VP slot?! Oh, that's very differe
blackhawks blackhawks 4 minutes ago
Vance is worse. The contemptuous remarks he made about Trump in '16 were prescient. He is an unprincipled, ends justify the means, windsock and a moral imbecile. Similar to Trump, but worse for someone with a law degree.

J.D do your Emily Litella: The VP slot?! Oh, that's very differe
MRJ25 MRJ25 4 minutes ago
If...after a jury has condemned the FHFA for the third amendment (in the case of fannie pfd's, with interest since it was signed), it would be very strange if the third amendment continued to be valid.

Yes, I am not a lawyer, but some other people here have mentioned that if this ruli
FNMA
ergo sum ergo sum 4 minutes ago
Suddenly the whole country things the NYT was right in the first place.
madras50 madras50 5 minutes ago
So is there any similarity in their story?
SLNA
theorysuit theorysuit 5 minutes ago
Dude you are paranoid beyond belief. Nothing you say or i say means anything. Ultimately the company must execute, and it sure doesn't look like they can. The focus has always been on LP and her enrichment.
NWBO
ksquared ksquared 6 minutes ago
Kamala Harris Supporters Fear Democrat Women Losing Elections Causes PTSD
(Oh, puh-leeze...)
AMY FURR 23 Jul 2024 2:22 Some social media users who commented on the Occupy Democrats post did not appear to be on board with a possible Harris presidency... “No one voted f
weedisgreen weedisgreen 7 minutes ago
I think it will pop up to that when they announce uplisting and then come down with a slow rise back up. Back in the spring a watched a podcast at some event that talked to a tune of the institutional investors already doing their homework. I'm also feeling confident that Kim already has been gett
TCNNF
capgain capgain 7 minutes ago
Could very well be. It wouldn't surprise me any, and we'll probably never know.
Jaxxm Jaxxm 8 minutes ago
Maybe tomorrow 1 dollar plus
HOLO
CaptBeer CaptBeer 8 minutes ago
$AMRN Here’s a fun Bonus Graphic showing the first 10-month Launch of VASCEPA® (USA) vs. VAZKEPA® (UK). VASCEPA® Launched in the USA in January 2013 and VAZKEPA® launched in October 2022.
For comparison purposes, consider:

1. Potential Patient Populations.
AMRN
thistraderknowsall thistraderknowsall 9 minutes ago
#1 MOMO BREAKOUT..ASM Altcoin to $1 online in a few minutes !!! We win!! Congrats!!!
ASM
Lone Clone Lone Clone 10 minutes ago
ARK, OGC, SNAG, ODV, TUO

Kazakhstan explorer Arras Minerals aka ARK announced the initiation of an airborne geophysical survey across its Maisor and Aktasty properties, which cover 1397 sq km and are part of the Exploration Alliance with Teck. They surround the large operating Bozshak
TUD
HyGro HyGro 10 minutes ago
Except for the 8 peer reviewed articles that challenge the legitimacy of the clinical trial revisions done 2 weeks before the completion of the trial.

Totally new comparator (one required to be approve BEFORE the trial started), change the protocol, endpoints, and experimental design
NWBO
devil dog 96 devil dog 96 10 minutes ago
This is all lies. 😆 I have never seen so many lies in one post 🤡 LMAO

" I’ve not ever bought this pig, ,not as pos tron.
Not as pos atmh.
Nor would I ever.
Only a freakin moron would.imo "

The no proof scam theory promo is a total sh
ATMH
Hercules1 Hercules1 10 minutes ago
What happened to water chaser?


Let me take a guess:

He is covered in shit.

From shitting all over himself.
HIRU
shigtynodigty shigtynodigty 10 minutes ago
I am hoping that reverse split doesn’t happen in 2 years and they can get over the 1.00 price
CHUC
FACT-MASTER FACT-MASTER 11 minutes ago
BLX: AH Price/Volume on FIRE!!

Last at $35.05 / 31,000 shares traded AH. ( at the moment)

https://www.nasdaq.com/market-activity/stocks/blx/after-hours
BLX
shigtynodigty shigtynodigty 11 minutes ago
Big time
CHUC
jazz5201 jazz5201 11 minutes ago
Bashers are going to be working overtime tonight to twist and turn things.

This is just the beginning.

Pennies soon...
SPZI

Your Recent History

Delayed Upgrade Clock